Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal morphine PCA versus continuous infusion for intractable cancer pain
2008-005087-14Phase 2Active
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of morphine in Intractable cancer pain (ICP) (2 arms), sponsored by Institut Cancérologique de l'Ouest. Primary endpoints: Pain intensity at rest and during activity, Catheter complications and 5 more. Started Oct 2008; status: active.
02
Drugs
morphine
03
Conditions
Intractable cancer pain (ICP)
Beyond the preview
Go deeper on 2008-005087-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005087-14.